Viewing Study NCT07271667


Ignite Creation Date: 2025-12-25 @ 12:38 AM
Ignite Modification Date: 2025-12-25 @ 10:49 PM
Study NCT ID: NCT07271667
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-09
First Post: 2025-11-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies
Sponsor: Curis, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module